Compare
VADs
Functional
Generations 4 & 5
|
Press
Release
MicroMed’s HeartAttendant Console with Remote
Monitoring
Receives CE Approval for Use in Europe
MicroMed 1st in Industry to Offer Remote Home Monitoring
of
HeartAssist 5™ Left Ventricular Assist Device
Patients
HOUSTON – April
21, 2010– On April 21, MicroMed Cardiovascular,
Inc. (www.micromedcv.com), manufacturer of the HeartAssist
5™ left ventricular assist device (LVAD), announced
it has received CE approval of its HeartAttendant™
console with remote monitoring capability for use in Europe. MicroMed
is the first in the industry to offer clinicians remote
monitoring capability of real-time and stored performance data
for the HeartAssist 5 LVAD via the internet.
When going to bed, or when requested
by a healthcare professional, patients connect their
HeartAssist 5 controller to the HeartAttendant, which
collects and stores blood flow data. This data is then
transmitted via a secure Internet connection. The healthcare
provider can access this data through their computer
using a unique name and password
to protect patient privacy. The HeartAttendant also
displays battery charge levels, power usage and mean
flow, and reconditions and charges up to four batteries
at once.
MicroMed also announced the formation
of its European Subsidiary, MicroMed BV, based in Uden,
Netherlands. This facility will provide complete inventory,
logistics and quality monitoring systems to support
MicroMed’s new European Sales and Customer Support
Team for launching the HeartAssist 5 in Europe.
“We are returning to the
European arena with an improved LVAD, which has received
the CE Mark and achieved extremely encouraging lab results,”
said Bill Birdsall, CEO of MicroMed. “The HeartAssist
5 and the HeartAttendant combine to provide a complete
patient care and management system. To provide increased
support for HeartAssist 5 customers, MicroMed is building
an experienced and highly effective organization in
Europe.”
###
In Europe, the HeartAssist
5™ has CE Marks for both adult and pediatric use.
In the U.S., the HeartAssist 5 is the only FDA-approved
pediatric VAD. An IDE clinical study is currently underway
in the U.S. for adults.
Media Contact:
Don
Isaacs
Director of Communications
MicroMed
Cardiovascular
Cell: (520) 955-0660
Resources for Reporters
|
